Delagardelle C, Harf C, Dondelinger R F, Goffette P, Beissel J, Pesch C, Welter R
Département de cardiologie, centre hospitalier de Luxembourg.
Arch Mal Coeur Vaiss. 1990 Jan;83(1):113-5.
The authors report the case of a patient treated by subcutaneous injection of calcium heparin after deep vein thrombosis with floating thrombus and pulmonary embolism. She was readmitted to hospital after 16 days' treatment because of a massive aorto-iliac thrombosis due to heparin-induced thrombocytopenia (platelet count = 29.000). This thrombosis was treated by local injection of Urokinase (total dose = 7.425.000 U) over 93 hours without any major complications. The aorto-iliac circulation was completely restored to normal after treatment. Thrombotic complications secondary to immuno-allergic heparin-induced thrombocytopenia are relatively common because of the widespread use of heparin. From the therapeutic point of view, it is imperative to stop the heparin, which makes surgery very difficult, and the platelet-fibrin composition of these thrombi suggests that local thrombolysis with Urokinase is the treatment of choice in this syndrome.
作者报告了1例深静脉血栓形成合并漂浮血栓及肺栓塞患者,经皮下注射肝素钙治疗的病例。治疗16天后,因肝素诱导的血小板减少症(血小板计数=29,000)导致严重的主-髂动脉血栓形成,患者再次入院。通过在93小时内局部注射尿激酶(总剂量=7,425,000单位)治疗该血栓形成,未出现任何严重并发症。治疗后主-髂动脉循环完全恢复正常。由于肝素的广泛使用,免疫-过敏性肝素诱导的血小板减少症继发的血栓形成并发症相对常见。从治疗角度来看,必须停用肝素,这使得手术非常困难,而且这些血栓的血小板-纤维蛋白成分提示,尿激酶局部溶栓是该综合征的首选治疗方法。